Bristol Population Health Science Institute

Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, six months after second doses, study finds

20 July 2022

Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.

Excess weight almost doubles risk of womb cancer

19 April 2022

New research shows that lifelong excess weight almost doubles a woman’s risk of developing womb cancer*, according to a Cancer Research UK-funded study led by the University of Bristol and published today [19 April] in BMC Medicine**.

England-wide study first to show link between intimate partner violence, self-harm and suicidality

23 June 2022

A new study is the first to show that intimate partner violence (IPV) is strongly associated with self-harm and suicidality in both men and women, and across all ages in England.

Scientists discover genes that affect the risk of developing pre-leukaemia

14 July 2022

The discovery of 14 inherited genetic changes which significantly increase the risk of a person developing a symptomless blood disorder associated with the onset of some types of cancer and heart disease is published today [July 14] in Nature Genetics. The finding, made in one of the largest studies of its kind through genetic data analysis on 421,738 people, could pave the way for potential new approaches for the prevention and early detection of cancers including leukaemia.

Paramedic techniques used during cardiac arrest similarly effective, study shows

29 August 2018

The two most widely used techniques used by paramedics to support a patient's breathing during cardiac arrest are similarly effective, a major new clinical trial has revealed.

“Hope saved my life”: How the Hope project helped men at risk of suicide

14 July 2022

A project to help men aged 30-64 who are at risk of suicide has saved lives and reduced depression and suicidal thoughts, a study by National Institute for Health and Care Research (NIHR) funded researchers at the University of Bristol has shown. Hope, run by mental health charity Second Step, aims to help men in mental health crisis because of debt, financial, employment or welfare difficulties.

Pioneering new gambling harms research hub launched at University of Bristol

17 May 2022

A £4 million Bristol Hub for Gambling Harms Research has been launched to build greater understanding and evidence around the growing and diverse impact of gambling harms across Great Britain.

Risk of blood clots remains for almost a year after COVID-19 infection, study suggests

20 September 2022

COVID-19 infection increases the risk of potentially life-threatening blood clots for at least 49 weeks, according to a new study of health records of 48 million unvaccinated adults from the first wave of the pandemic.

Significant gaps and inequalities in the provision of specialist child weight management services in England, study finds

30 November 2022

Over three quarters of acute NHS trusts in England (77%) do not have a child weight management service, despite being responsible for providing specialist services for the most severely obese, according to a study led by researchers at the University of Bristol and funded by the National Institute for Health and Care Research (NIHR).

Incarceration is likely to increase HIV and HCV transmission among people who inject drugs, new study finds

29 October 2018

Injecting drug use, through the sharing of needles, syringes and other injecting equipment, is a primary route of transmission for both HIV and hepatitis C virus (HCV), blood-borne infections that cause considerable morbidity and mortality worldwide. New research led by the University of Bristol has found among people who inject drugs, that recent incarceration was associated with an 81 per cent and 62 per cent increase in HIV and HCV acquisition risk, respectively.